DK0507851T3 - Quinoloncarboxylsyre-matalion-syrekomplekser - Google Patents

Quinoloncarboxylsyre-matalion-syrekomplekser

Info

Publication number
DK0507851T3
DK0507851T3 DK91902370.5T DK91902370T DK0507851T3 DK 0507851 T3 DK0507851 T3 DK 0507851T3 DK 91902370 T DK91902370 T DK 91902370T DK 0507851 T3 DK0507851 T3 DK 0507851T3
Authority
DK
Denmark
Prior art keywords
quinolone
acid complexes
matalion
compositions
quinolone carboxylic
Prior art date
Application number
DK91902370.5T
Other languages
English (en)
Inventor
Laman A Al-Razzak
Francisco J Alvarez
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23822659&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0507851(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK0507851T3 publication Critical patent/DK0507851T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic System
    • C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic System without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/06—Aluminium compounds
    • C07F5/069—Aluminium compounds without C-aluminium linkages
DK91902370.5T 1989-12-29 1990-12-20 Quinoloncarboxylsyre-matalion-syrekomplekser DK0507851T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45892789A 1989-12-29 1989-12-29

Publications (1)

Publication Number Publication Date
DK0507851T3 true DK0507851T3 (da) 1997-08-25

Family

ID=23822659

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91902370.5T DK0507851T3 (da) 1989-12-29 1990-12-20 Quinoloncarboxylsyre-matalion-syrekomplekser

Country Status (14)

Country Link
US (1) US5334589A (da)
EP (1) EP0507851B1 (da)
JP (1) JP3153549B2 (da)
AT (1) ATE150973T1 (da)
AU (1) AU647772B2 (da)
CA (1) CA2072366C (da)
DE (1) DE69030387T2 (da)
DK (1) DK0507851T3 (da)
ES (1) ES2102393T3 (da)
GR (1) GR3023542T3 (da)
IE (1) IE904725A1 (da)
IL (1) IL96776A (da)
PT (1) PT96400B (da)
WO (1) WO1991009525A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9118183D0 (en) * 1991-08-23 1991-10-09 Solanki Kishor K Imaging of infections
US5290794A (en) * 1992-10-27 1994-03-01 Warner Lambert Co. Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms
US6024979A (en) * 1995-06-06 2000-02-15 Solvay Animal Health, Inc. Oral veterinary composition containing a fluoroquinolone antibacterial agent possessing superior absorption properties and an extended duration of therapeutic antimicrobial blood levels, and a method of treating a microbial infection in a ruminant
UA56151C2 (uk) * 1995-12-21 2003-05-15 Пфайзер, Інк. Водний ін'єкційний розчин данофлоксацину (варіанти) та спосіб лікування бактеріальних інфекцій
ID21415A (id) 1997-12-05 1999-06-10 Upjohn Co Senyawa-senyawa antibiotik magnesium quinolon
DE19937116A1 (de) 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
DE19937115A1 (de) 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
DE10018781A1 (de) * 2000-04-15 2001-10-25 Fresenius Kabi De Gmbh Infusionslösungen des Ciprofloxacins mit verbesserter Lagerfähigkeit
WO2006004028A1 (ja) * 2004-07-02 2006-01-12 Daiichi Pharmaceutical Co., Ltd. キノロン含有医薬組成物
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US7838532B2 (en) * 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US20070197548A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
NZ607408A (en) 2008-10-07 2014-10-31 Mpex Pharmaceuticals Inc Aerosol fluoroquinolone formulations for improved pharmacokinetics
PT2346509T (pt) 2008-10-07 2020-08-05 Horizon Orphan Llc Inalação de levofloxacina para redução da inflamação pulmonar
PL2473170T3 (pl) 2009-09-04 2020-03-31 Horizon Orphan Llc Zastosowanie lewofloksacyny w aerozolu do leczenia mukowiscydozy
WO2016195014A1 (ja) 2015-06-02 2016-12-08 杏林製薬株式会社 水性液剤
JP6675396B2 (ja) 2015-06-02 2020-04-01 杏林製薬株式会社 水性液剤
WO2016195021A1 (ja) 2015-06-02 2016-12-08 杏林製薬株式会社 水性液剤
CN105524060B (zh) * 2016-03-10 2017-03-22 青岛云天生物技术有限公司 一种制备盐酸莫西沙星的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ208470A (en) * 1983-07-18 1988-06-30 Abbott Lab 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such
US4730000A (en) * 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
DE3333719A1 (de) * 1983-09-17 1985-04-04 Bayer Ag Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
DE3713672A1 (de) * 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
JP2832535B2 (ja) * 1989-04-04 1998-12-09 富山化学工業株式会社 キノロンカルボン酸またはその塩の可溶化法
FR2665635A1 (fr) * 1990-08-10 1992-02-14 Merck Sharp & Dohme Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation.

Also Published As

Publication number Publication date
EP0507851A4 (en) 1993-03-17
DE69030387T2 (de) 1997-10-23
AU7153191A (en) 1991-07-24
CA2072366A1 (en) 1991-06-30
IE904725A1 (en) 1991-07-17
IL96776A (en) 1997-02-18
ES2102393T3 (es) 1997-08-01
CA2072366C (en) 2002-08-20
WO1991009525A1 (en) 1991-07-11
GR3023542T3 (en) 1997-08-29
PT96400B (pt) 1998-06-30
AU647772B2 (en) 1994-03-31
JPH05502879A (ja) 1993-05-20
PT96400A (pt) 1991-10-15
JP3153549B2 (ja) 2001-04-09
IL96776A0 (en) 1991-09-16
DE69030387D1 (de) 1997-05-07
ATE150973T1 (de) 1997-04-15
EP0507851B1 (en) 1997-04-02
US5334589A (en) 1994-08-02
EP0507851A1 (en) 1992-10-14

Similar Documents

Publication Publication Date Title
ATE150973T1 (de) Chinoloncarbonsäure-metallionsäurekomplexe
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
PH23256A (en) A process for the preparation of quinolone carboxylic acid derivatives
IT1223290B (it) Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche
MY110734A (en) Improvements in or relating to dioic acids.
SE9301290D0 (sv) Anvaendning av en somatostatinanalog
DE3650358D1 (de) Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis.
TR200002078T2 (tr) Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
DE3880587D1 (de) Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose.
ATE116849T1 (de) Pharmazeutische verwendung von fettsäuren.
SE8701077D0 (sv) Pharmaceutical composition
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
DK15088A (da) Antibakterielt lyofiliseret praeparat
DE68928488T2 (de) Zusammensetzungen und verabreichungsverfahren für heilmittel
ATE173925T1 (de) Lösliche calciumlaktat/chinoloncarbonsäuren komplexe als nichtreizende parenterale verabreichungsformen
DE69941459D1 (de) Verfahren zur herstellung von essbaren zusammenstellungen mit antibakteriellen wirkstoffen
KR890001555A (ko) 요산 배설용 조성물